Vancouver, British Columbia
Joined May 2013
Faraz Hach retweeted
Our work on Freddie, an annotation-indepented isoform discovery using long-reads tool, is finally published at @NAR_Open! Check the open access code and paper: 📄: academic.oup.com/nar/advance… 💾: github.com/vpc-ccg/freddie/ 🐍: conda install -c bioconda freddie
1
2
6
Call For Papers is out, key dates announced: Paper submission: Oct 7, 2022 Notification: Nov 20, 2022 Final versions due: Jan 8, 2023 More at recomb2023.bilkent.edu.tr/ke… and recomb2023.bilkent.edu.tr/ca…
1
22
4
49
Faraz Hach retweeted
Our latest manuscript by Ghazal Ebrahimi and @baraaorabi is now published by @iScience_CP! "Fast and accurate matching of cellular barcodes across short-reads and long-reads of single-cell RNA-seq experiments" 💾: github.com/vpc-ccg/scTagger 📃: sciencedirect.com/science/ar…
1
3
1
9
📢ANNOUNCEMENT: The 2021 Scholar & Research Trainee awardees are advancing science and contributing to world-class #health #research in BC to ultimately improve the health of British Columbians. Meet the 86 recipients: bit.ly/3nmkcyn #MSFHRCommunity
3
14
52
59
I'll also be talking about mdBG in this year's RECOMB on Tuesday, August 31 at 3PM. Happening virtually, and free! xitter.cf/recomb21/status/142222…
Some updates! 🎆 The program for #RECOMB2021, featuring six distinguished keynote speakers, is now available! recomb2021.org/program To maximize the opportunity for every member of the community to join #RECOMB2021, we will offer #free registration to the conference! ⬇️
1
3
9
Faraz Hach retweeted
Very proud of the latest work from our lab were we aimed to understand why there are vastly more androgen receptor binding sites (ARBS) than AR-regulated genes. We functional tested all common clinical binding sites and found.....genomebiology.biomedcentral.…👇1/n
5
17
7
67
Faraz Hach retweeted
The paper deadline for RECOMB-Seq 2021 is coming up on March 22! Check out the website for more information. recomb2021.org/recomb-seq-sa…
8
9
Today is #WorldCancerResearchDay and we can't think of a better way to celebrate it than to share this picture of TFRI-funded researchers coming together to honour Terry's legacy. We want the world to know how committed we are to finding new cures for cancer...TOGETHER.
18
53
Faraz Hach retweeted
Checkmate, Chromosome 8: The First End-to-End Sequence of a Human Autosome. Congrats to @glennis_logsdon & the #T2T team on this amazing work! ow.ly/C6xx50Bx40T #HiFiReads
I'll give a talk tomorrow on indexing k-mers, 8pm CET, public Zoom link below
Our next #VanBUG webinar, by Dr. @RayanChikhi, on "Efficient indexing of k-mer presence and abundance in sequencing datasets", is coming up Wed, Sep 16th 11-12:30pm PST! Zoom Link posted day of event. More details @ vanbug.org #Bioinformatics
2
16
37
Faraz Hach retweeted
Long reads weighing down your genome assembly speed? HASLR is a hybrid assembler combining short and long reads to speed it up @f_hach @SFU @RECOMBSeq @RECOMB2020 bit.ly/2RxFuIt Editor @tonzani
4
5
Faraz Hach retweeted
Our next #VanBUG webinar, by Dr. @RayanChikhi, on "Efficient indexing of k-mer presence and abundance in sequencing datasets", is coming up Wed, Sep 16th 11-12:30pm PST! Zoom Link posted day of event. More details @ vanbug.org #Bioinformatics
Faraz Hach retweeted
WABI 2020 was an awesome virtual conference. Luckily, even if you didn't have a chance to attend, you can watch the talks — algo2020.di.unipi.it/program… !
16
37
Detecting High Scoring Local Alignments in Pangenome Graphs biorxiv.org/cgi/content/shor… #bioRxiv
1
4
Faraz Hach retweeted
Our fast hybrid assembler tool, HASLR, just got published by @iScience_CP! Congrats to @haghshenas_e for getting his final PhD work out 🎉 📜: cell.com/iscience/fulltext/S… 💾: github.com/vpc-ccg/haslr 🐍: conda install -c bioconda haslr
4
13
Faraz Hach retweeted
I'm very excited to have the pre-print out for puffaligner, an efficient alignment tool based on the pufferfish index (biorxiv.org/content/10.1101/…). This has been a monumental work by Mohsen and @fataltes in terms of design, engineering, testing and benchmarking. 1/10
3
42
2
130